Bernhardt Zeiher
Fortune : 738 350 $ au 30/06/2026
Fortune : 738 350 $ au 30/06/2026
Bernhardt G.
Zeiher is currently an Independent Director at Entrada Therapeutics, Inc. since 2023, Amylyx Pharmaceuticals, Inc. since 2024, and Abeona Therapeutics, Inc. since 2024.
Former positions include Director roles at Biotechnology Innovation Organization, Astellas Global Health Foundation, and Transcelerate Biopharma, Inc. Served as Associate Medical Director at Merck & Co., Inc. from 1998 to 2000.
Served as President of Astellas Pharma Global Development, Inc. from 2015 to 2019.
Served as Chief Medical Officer at Astellas Pharma, Inc. from 2018 to 2022.
Education includes undergraduate studies at the University of Toledo (Ohio) and a doctorate from Case Western Reserve University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 15/04/2026 | 84 458 ( 0,15% ) | 521 950 $ | 30/06/2026 | |
| 04/06/2026 | 10 000 ( 0,01% ) | 179 600 $ | 30/06/2026 | |
| 10/06/2026 | 5 000 ( 0,01% ) | 36 800 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 04/04/2023 |
| AMYLYX PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 14/03/2024 |
| ABEONA THERAPEUTICS INC. | Directeur/Membre du Conseil | 08/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
| ASTELLAS PHARMA INC. | Directeur Technique/Scientifique/R&D | 01/01/2022 |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | President | 01/01/2019 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2000 |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 10 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Abeona Therapeutics, Inc.
Abeona Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes cell and gene therapies for life-threatening rare genetic diseases | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
University of Toledo (Ohio)
University of Toledo (Ohio) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma, Inc.
Astellas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals and related medical products | Health Technology |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Case Western Reserve University School of Medicine
Case Western Reserve University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products to cure neurodegenerative diseases | Health Technology |
Entrada Therapeutics, Inc.
Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national